![David A. Burns](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David A. Burns
Directeur Général chez
Cellectricon AB
Profil
David A. Burns currently works at Cellectricon AB, as Chief Executive Officer & Director from 2011.
Mr. Burns also formerly worked at Hammersmith Imanet Ltd., as Chief Executive Officer, GE Healthcare Niagara, Inc., as Chief Executive Officer, Renishaw Diagnostics Ltd., as Chief Executive Officer, Isogenica Ltd., as Non-executive Director, Packard BioScience Co., as Principal, Cyntellect, Inc., as Chief Operating Officer & VP-Sales & Marketing from 2008 to 2010, Pharmacia LKB Biotechnology, Inc., as Principal, PerkinElmer BioSignal, Inc., as Vice President-Business Development & Marketing, and GE UK Group, as Head-Strategic Growth & VP-Commercial Alliances.
Mr. Burns received his undergraduate degree from Napier University.
Postes actifs de David A. Burns
| Sociétés | Poste | Début |
|---|---|---|
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Directeur Général | 21/09/2011 |
Anciens postes connus de David A. Burns
| Sociétés | Poste | Fin |
|---|---|---|
Packard BioScience Co.
 Packard BioScience Co. Medical SpecialtiesHealth Technology Manufactures nuclear measurement instruments and systems | Corporate Officer/Principal | - |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Directeur/Membre du Conseil | - |
PerkinElmer BioSignal, Inc.
 PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets cloned drug targets as drug screening reagents | Sales & Marketing | - |
GE Healthcare Niagara, Inc. | Directeur Général | - |
Renishaw Diagnostics Ltd.
 Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops and commercializes systems to provide in vitro diagnosis of infectious diseases | Directeur Général | - |
Formation de David A. Burns
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Packard BioScience Co.
Packard BioScience Co. Medical SpecialtiesHealth Technology Manufactures nuclear measurement instruments and systems | Health Technology |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Cyntellect, Inc.
 Cyntellect, Inc. Miscellaneous Commercial ServicesCommercial Services Develops life science technologies | Commercial Services |
Hammersmith Imanet Ltd. | |
Napier University
 Napier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia LKB Biotechnology, Inc. | |
PerkinElmer BioSignal, Inc.
PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets cloned drug targets as drug screening reagents | Commercial Services |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
GE UK Group
 GE UK Group MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
GE Healthcare Niagara, Inc. | |
Renishaw Diagnostics Ltd.
Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops and commercializes systems to provide in vitro diagnosis of infectious diseases | Health Technology |
